Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -466,456 | -65,761 | -199,228 | -2,483 | 32,779 |
| Depreciation Amortization | 42,471 | 187,968 | 170,235 | 112,615 | 82,634 |
| Income taxes - deferred | 404 | 41,166 | -178,421 | 7,279 | 5,007 |
| Accounts receivable | -18,816 | 16,995 | -14,978 | -9,906 | -36,913 |
| Other Working Capital | 6,365 | -13,371 | 2,728 | 57,675 | -53,594 |
| Other Operating Activity | 310,336 | -106,197 | 326,260 | 81,042 | 66,068 |
| Operating Cash Flow | $-125,696 | $60,800 | $106,596 | $246,222 | $95,981 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 83,506 | -4,614 | 167,708 | -67,244 | N/A |
| PPE Investments | -2,544 | -2,534 | -8,988 | -5,460 | -1,259 |
| Net Acquisitions | N/A | 519,303 | N/A | N/A | -681,794 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -424,759 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 208,966 |
| Purchase Sale Intangibles | N/A | N/A | -55,800 | 0 | N/A |
| Other Investing Activity | -60,000 | -10,000 | -55,800 | 0 | -195 |
| Investing Cash Flow | $20,962 | $502,155 | $102,920 | $-72,704 | $-899,041 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 320,000 | 0 | 834,750 |
| Debt Repayment | -21,417 | -503,054 | -545,480 | -17,502 | -327,509 |
| Common Stock Issued | 1,536 | 3,881 | 3,021 | 3,885 | 422,883 |
| Common Stock Repurchased | -13,730 | 0 | -19,466 | -20,000 | 0 |
| Other Financing Activity | -1,902 | -2,801 | -51,719 | -94,301 | -17,655 |
| Financing Cash Flow | $-35,513 | $-501,974 | $-293,644 | $-127,918 | $912,469 |
| Beginning Cash Position | 253,751 | 192,770 | 276,898 | 231,298 | 119,296 |
| End Cash Position | 113,504 | 253,751 | 192,770 | 276,898 | 228,705 |
| Net Cash Flow | $-140,247 | $60,981 | $-84,128 | $45,600 | $109,409 |
| Free Cash Flow | |||||
| Operating Cash Flow | -125,696 | 60,800 | 106,596 | 246,222 | 95,981 |
| Capital Expenditure | -2,544 | -2,534 | -8,988 | -5,460 | -1,259 |
| Free Cash Flow | -128,240 | 58,266 | 97,608 | 240,762 | 94,722 |